Functional heterogeneity, tumor vascularization, and the nonlinear dynamics of metastatic cancer treated by oncolytic viral therapy
Abstract
Oncolytic viral therapy (OVT) is an emerging cancer treatment where therapeutic viruses are injected into a patient. Models have been developed which describe the interactions of the virus, tumor and immune system through systems of nonlinear ordinary differential equations (ODEs). Some suggest that an initial phase of treatment with immunosuppressants could improve the efficacy of OVT by preventing the immune system from attacking the oncolytic viruses before they can infect many tumor cells. However, all such models have focused on a single, localized tumor. Here, we model a primary tumor and its continuous metastatic seeding of a secondary organ under simplifying assumptions about tumor vascularization. Bifurcation analysis and simulations reveal regions in parameter space for which immune modulation encourages distant metastasis, leading to the dangerous scenario where the elimination of a primary tumor creates the false impression of a good prognosis. We also suggest that vascular disrupting agents may be useful for treating small tumors while they may promote OVT resistance in larger tumors.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Qualitative Optimization of Oncolytic Virotherapy and Immune Therapy Combination Treatments
Negar Mohammadnejad, Thomas Hillen·Mathematical Biosciences & EngineeringPeer-reviewed·Jan 1, 2026
- Stacked Waves and Qualitative Analysis of an Oncolytic Virus-Immune Model
Negar Mohammadnejad, Thomas Hillen·Bulletin of Mathematical BiologyPeer-reviewed·Oct 3, 2026
- Modelling the spatial dynamics of oncolytic virotherapy in the presence of virus-resistant tumor cells
D. K. Bhatt, T. Janzen, … F. J. Weissing·bioRxiv·Apr 6, 2022
- Fighting cancer with oncolytic viral therapy: identifying threshold parameters for success
S. Jahedi, L. Wang, J. Watmough·bioRxiv·Jul 19, 2021
- Asymmetric drug effects drive near-extinction cancer cell oscillations in transgenic oncolytic virotherapy: A modelling study
Amaia Vielba-Trillo, Josep Sardanyés A, Tomás Alarcón·bioRxiv·Apr 29, 2026
- Modeling Oncolytic Vaccinia Virus Therapy Highlights Neutrophil Impact on Tumor Suppression
SAHAJ SATANI, Hana M. Dobrovolny·bioRxiv·Nov 6, 2024